Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Will a new contact lens beat a favorite? study tests comfort swap

NCT ID NCT06955403

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether people who are happy with their current Acuvue Oasys for Astigmatism contact lenses would like to switch to PRECISION7® for Astigmatism lenses. About 40 adults aged 18 to 40 who wear Acuvue Oasys lenses will try the new lenses and answer questions about comfort, vision, and overall satisfaction. The goal is to see how likely they are to keep wearing the new lenses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Nov 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

• Inclusion Criteria: Adults, 18- to 40-year-old, AOA CL wearers with best-corrected 20/20 visual acuity or better. * Participants will be required to have worn AOA CLs for at least 3 months in the past year and currently wearing these CLs. * All participants will be required to have a CLDEQ-8 score \<12 while wearing their habitual CLs (AOA CLs) and to indicate that they are satisfied with AOA CLs (Yes/No). * Participants will be required to be able to wear P7A CLs (astigmatism ≥0.75D OD/OS). * Astigmatism ranging from 0.75 D to 2.50 D in each eye * Participants will be required to wear the study CLs for ≥13 hours with no overnight wear * Participants will be willing to wear the CL every day of the week, except during the washout period * Participants will be required to provide a glasses prescription that is less than 3 years old * \- * Exclusion Criteria: * \- Have presbyopia and/or need a reading add as determined during their initial manifest refraction * Have worn P7A in the past * Are past rigid CL wearers * Have a history of being diagnosed with dry eye or ocular allergies * Have known systemic health conditions that are thought to alter tear film physiology * Have a history of viral eye disease * Have a history of ocular surgery * Have a history of severe ocular trauma * Have a history of corneal dystrophies or degenerations * Have active ocular infection or inflammation * Are currently using isotretinoin-derivatives or ocular medications * Are pregnant or breast feeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Astigmatism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Southern College of Optometry

    RECRUITING

    Memphis, Tennessee, 38104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.